The relationship between uric acid levels and Huntington's disease progression
- 30 January 2010
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 25 (2), 224-228
- https://doi.org/10.1002/mds.22907
Abstract
Uric acid (UA) may be associated with the progression of Parkinson's disease and related neurodegenerative conditions; however, its association with Huntington's disease (HD) progression has not been explored. A secondary analysis of 347 subjects from the CARE‐HD clinical trial was performed to examine the relationship between baseline UA levels and the level of functional decline in HD. Outcomes included change in scores at 30 months for the Unified Huntington's Disease Rating Scale components. There was less worsening of total functional capacity over time with increasing baseline UA levels (adjusted mean worsening in scores: 3.17, 2.99, 2.95, 2.28, 2.21, from lowest to highest UA quintile, P = 0.03). These data suggest a possible association between higher UA levels and slower HD progression, particularly as measured by total functional capacity. If confirmed, UA could be an important predictor and potentially modifiable factor affecting the rate of HD progression. © 2009 Movement Disorder SocietyFunding Information
- NIH
- NINDS (#NS R01-35284)
- General Clinical Research Centers (RR00052, RR00645, RR00042, RR00044, RR01066, RR07122)
- Astra-Zeneca
- Vitaline
This publication has 16 references indexed in Scilit:
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson DiseaseArchives of Neurology, 2008
- Decreased plasma antioxidants in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2006
- Serum uric acid levels and the risk of Parkinson diseaseAnnals of Neurology, 2005
- Mitochondria take center stage in aging and neurodegenerationAnnals of Neurology, 2005
- A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington’s diseaseNeurology, 2001
- Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivoJournal of Neuroscience Research, 1998
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- Validation of the brief test of attention in patients with huntington's disease and amnesiaThe Clinical Neuropsychologist, 1996
- Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortexJournal of the Neurological Sciences, 1992
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences of the United States of America, 1981